NasdaqGS:IONSBiotechs
Has Ionis Pharmaceuticals (IONS) Run Too Far After Its 152% One Year Surge?
If you are wondering whether Ionis Pharmaceuticals at US$83.88 is starting to look expensive or still offers value, you are not alone.
The stock has returned 2.6% over the last 7 days, 6.2% over 30 days, 5.3% year to date and 151.7% over the past year, with 103.6% over 3 years and 41.2% over 5 years, which will naturally shape how investors think about its risk and return profile.
Recent coverage around Ionis has focused on its position in the pharmaceuticals and biotech space, where...